BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 38041130)

  • 1. Identification of differentially expressed genes associated with the pathogenesis of gastric cancer by bioinformatics analysis.
    Abdolahi F; Shahraki A; Sheervalilou R; Mortazavi SS
    BMC Med Genomics; 2023 Dec; 16(1):311. PubMed ID: 38041130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
    Li T; Gao X; Han L; Yu J; Li H
    World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics Analysis of Key Genes and circRNA-miRNA-mRNA Regulatory Network in Gastric Cancer.
    Tian Y; Xing Y; Zhang Z; Peng R; Zhang L; Sun Y
    Biomed Res Int; 2020; 2020():2862701. PubMed ID: 32908877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatics Analysis of Hub Genes and Potential Therapeutic Agents Associated with Gastric Cancer.
    Zhang S; Xiang X; Liu L; Yang H; Cen D; Tang G
    Cancer Manag Res; 2021; 13():8929-8951. PubMed ID: 34876855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
    Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
    Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics analysis identifies COL1A1, THBS2 and SPP1 as potential predictors of patient prognosis and immunotherapy response in gastric cancer.
    Wang Y; Zheng K; Chen X; Chen R; Zou Y
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33345281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Hub Genes and Pathways in Gastric Adenocarcinoma Based on Bioinformatics Analysis.
    Qiu J; Sun M; Wang Y; Chen B
    Med Sci Monit; 2020 Feb; 26():e920261. PubMed ID: 32058995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis.
    Li D; Yin Y; He M; Wang J
    Med Sci Monit; 2021 Feb; 27():e929104. PubMed ID: 33582701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying hub genes and miRNAs in Crohn's disease by bioinformatics analysis.
    Sun Y; Cai D; Hu W; Fang T
    Front Genet; 2022; 13():950136. PubMed ID: 36118873
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of hub genes and potential molecular mechanisms in gastric cancer by integrated bioinformatics analysis.
    Cao L; Chen Y; Zhang M; Xu DQ; Liu Y; Liu T; Liu SX; Wang P
    PeerJ; 2018; 6():e5180. PubMed ID: 30002985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of survival-associated biomarkers based on three datasets by bioinformatics analysis in gastric cancer.
    Yin LK; Yuan HY; Liu JJ; Xu XL; Wang W; Bai XY; Wang P
    World J Clin Cases; 2023 Jul; 11(20):4763-4787. PubMed ID: 37584004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of potential core genes in gastric cancer using bioinformatics analysis.
    Shao C; Wang R; Kong D; Gao Q; Xu C
    J Gastrointest Oncol; 2021 Oct; 12(5):2109-2122. PubMed ID: 34790378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of differentially expressed genes regulated by molecular signature in breast cancer-associated fibroblasts by bioinformatics analysis.
    Vastrad B; Vastrad C; Tengli A; Iliger S
    Arch Gynecol Obstet; 2018 Jan; 297(1):161-183. PubMed ID: 29063236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics Analysis and Identification of Potential Genes Associated with Pathogenesis and Prognosis of Gastric Cancer.
    Wang DW; Su F; Yang LJ; Shi LW; Yang TC; Wang HQ; Li XF; Feng MH
    Curr Med Sci; 2022 Apr; 42(2):357-372. PubMed ID: 35325407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of NCAPG, KNL1, miR-148a-3p, miR-193b-3p, and miR-1179 may contribute to the progression of gastric cancer.
    Song B; Du J; Song DF; Ren JC; Feng Y
    Biol Res; 2018 Nov; 51(1):44. PubMed ID: 30390708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Core Prognosis-Related Candidate Genes in Chinese Gastric Cancer Population Based on Integrated Bioinformatics.
    Li M; Wang X; Liu J; Mao X; Li D; Wang Z; Tang Y; Wu S
    Biomed Res Int; 2020; 2020():8859826. PubMed ID: 33381592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying Diagnostic and Prognostic Biomarkers and Candidate Therapeutic Drugs of Gastric Cancer Based on Transcriptomics and Single-Cell Sequencing.
    Zhao X; Wu S; Jing J
    Pathol Oncol Res; 2021; 27():1609955. PubMed ID: 34899080
    [No Abstract]   [Full Text] [Related]  

  • 18. Microarray profile analysis identifies ETS1 as potential biomarker regulated by miR-23b and modulates TCF4 in gastric cancer.
    Mei D; Qi Y; Xia Y; Ma J; Hu H; Ai J; Chen L; Wu N; Liao D
    World J Surg Oncol; 2021 Oct; 19(1):311. PubMed ID: 34686186
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Yan P; He Y; Xie K; Kong S; Zhao W
    PeerJ; 2018; 6():e6092. PubMed ID: 30568862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL8, MMP12, and MMP13 are common biomarkers of periodontitis and oral squamous cell carcinoma.
    Chen X; Lei H; Cheng Y; Fang S; Sun W; Zhang X; Jin Z
    Oral Dis; 2024 Mar; 30(2):390-407. PubMed ID: 36321868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.